Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Kraig Biocraft Laboratories (KBLB) EPS (Basic) (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed EPS (Basic) for 10 consecutive years, with -$0.0 as the latest value for Q3 2022.

  • Quarterly EPS (Basic) rose 77.46% to -$0.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$0.0 through Sep 2022, up 55.08% year-over-year, with the annual reading at -$0.01 for FY2021, 0.0% changed from the prior year.
  • EPS (Basic) hit -$0.0 in Q3 2022 for Kraig Biocraft Laboratories, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q2 2018 to a low of -$0.0 in Q3 2021.
  • Historically, EPS (Basic) has averaged -$0.0 across 4 years, with a median of -$0.0 in 2022.
  • Biggest five-year swings in EPS (Basic): skyrocketed 85.68% in 2018 and later tumbled 430.31% in 2019.
  • Year by year, EPS (Basic) stood at -$0.0 in 2018, then crashed by 121.98% to -$0.0 in 2019, then rose by 1.27% to -$0.0 in 2021, then skyrocketed by 37.45% to -$0.0 in 2022.
  • Business Quant data shows EPS (Basic) for KBLB at -$0.0 in Q3 2022, -$0.0 in Q2 2022, and -$0.0 in Q1 2022.